{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:13:15Z","timestamp":1787170395989,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scleroderma Australia"},{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CSL Biotherapies"},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000948","name":"Pfizer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1126370"],"award-info":[{"award-number":["APP1126370"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10067-018-4081-7","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:35:57Z","timestamp":1524443757000},"page":"1563-1571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations"],"prefix":"10.1007","volume":"37","author":[{"given":"Vivek","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"issue":"1","key":"4081_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto TR, Whitfield ML, Connolly MK (2011) The pathogenesis of systemic sclerosis. Annu Rev Pathol 6(1):509\u2013537. \n                    https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130312","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"4081_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12016-009-8193-3","volume":"40","author":"M Geyer","year":"2010","unstructured":"Geyer M, M\u00fcller-Ladner U (2010) The pathogenesis of systemic sclerosis revisited. Clin Rev Allergy Immunol 40(2):92\u2013103. \n                    https:\/\/doi.org\/10.1007\/s12016-009-8193-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"19","key":"4081_CR3","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360(19):1989\u20132003. \n                    https:\/\/doi.org\/10.1056\/NEJMra0806188","journal-title":"N Engl J Med"},{"issue":"3","key":"4081_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/acr.22121","volume":"66","author":"L Chung","year":"2014","unstructured":"Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, Fischer A, Frech T, Furst DE, Gomberg-Maitland M, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TA Jr, Molitor JA, Preston IR, Schiopu E, Shapiro L, Silver R, Simms R, Varga J, Gordon JK, Steen VD (2014) Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken) 66(3):489\u2013495. \n                    https:\/\/doi.org\/10.1002\/acr.22121","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"4081_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.berh.2016.03.004","volume":"30","author":"V Thakkar","year":"2016","unstructured":"Thakkar V, Lau EM (2016) Connective tissue disease-related pulmonary arterial hypertension. Best Pract Res Clin Rheumatol 30(1):22\u201338. \n                    https:\/\/doi.org\/10.1016\/j.berh.2016.03.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4081_CR6","unstructured":"Peacock A (2003) Prevention and early diagnosis of pulmonary hypertension. In: Demedts M, Delcroix M, Verhaege R, Verleden GM (eds) Pulmonary vascular pathology: a clinical update vol 27. Eur Respir Soc Monogr, Sheffield, pp 227\u2013242"},{"issue":"3","key":"4081_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrcardio.2014.191","volume":"12","author":"EM Lau","year":"2015","unstructured":"Lau EM, Humbert M, Celermajer DS (2015) Early detection of pulmonary arterial hypertension. Nat Rev Cardiol 12(3):143\u2013155. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2014.191","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"4081_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012106","volume":"5","author":"SA Pendergrass","year":"2010","unstructured":"Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, Lafyatis R (2010) Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One 5(8):e12106. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0012106","journal-title":"PLoS One"},{"issue":"6","key":"4081_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.1780400602","volume":"40","author":"CF Mojcik","year":"1997","unstructured":"Mojcik CF, Shevach EM (1997) Adhesion molecules: a rheumatologic perspective. Arthritis Rheum 40(6):991\u20131004. \n                    https:\/\/doi.org\/10.1002\/1529-0131(199706)40:6<991::AID-ART1>3.0.CO;2-G","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4081_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/107999099314234","volume":"19","author":"G Krishnaswamy","year":"1999","unstructured":"Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interf Cytokine Res 19(2):91\u2013104. \n                    https:\/\/doi.org\/10.1089\/107999099314234","journal-title":"J Interf Cytokine Res"},{"issue":"12","key":"4081_CR11","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/art.1780331214","volume":"33","author":"BW Needleman","year":"1990","unstructured":"Needleman BW (1990) Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients. Arthritis Rheum 33(12):1847\u20131851. \n                    https:\/\/doi.org\/10.1002\/art.1780331214","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4081_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000163881","volume":"62","author":"MM Cho","year":"1994","unstructured":"Cho MM, Jimenez SA, Johnson BA, Harlow LA, Burrows JC, Koch AE (1994) In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts. Pathobiology 62(2):73\u201381. \n                    https:\/\/doi.org\/10.1159\/000163881","journal-title":"Pathobiology"},{"issue":"5\u20136","key":"4081_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000163802","volume":"61","author":"AE Koch","year":"1993","unstructured":"Koch AE, Kronfeld-Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, Strieter RM, Kunkel SL, Massa MC, Barr WG, Jimenez SA (1993) In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiol 61(5\u20136):239\u2013246. \n                    https:\/\/doi.org\/10.1159\/000163802","journal-title":"Pathobiol"},{"issue":"7","key":"4081_CR14","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/rheumatology\/kep091","volume":"48","author":"BJ Rabquer","year":"2009","unstructured":"Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G, Gerber ML, Jimenez SA, Seibold JR, Koch AE (2009) The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatol 48(7):734\u2013740. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep091","journal-title":"Rheumatol"},{"issue":"11","key":"4081_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/rheumatology\/34.11.1048","volume":"34","author":"CP Denton","year":"1995","unstructured":"Denton CP, Bickerstaff MC, Shiwen X, Carulli MT, Haskard DO, Dubois RM, Black CM (1995) Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol 34(11):1048\u20131054. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/34.11.1048","journal-title":"Br J Rheumatol"},{"issue":"12","key":"4081_CR16","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/rheumatology\/36.12.1270","volume":"36","author":"H Ihn","year":"1997","unstructured":"Ihn H, Sato S, Fujimoto M, Kikuchi K, Kadono T, Tamaki K, Takehara K (1997) Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. Br J Rheumatol 36(12):1270\u20131275. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/36.12.1270","journal-title":"Br J Rheumatol"},{"issue":"1","key":"4081_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/clin.1993.1100","volume":"68","author":"PP Sfikakis","year":"1993","unstructured":"Sfikakis PP, Tesar J, Baraf H, Lipnick R, Klipple G, Tsokos GC (1993) Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 68(1):88\u201392. \n                    https:\/\/doi.org\/10.1006\/clin.1993.1100","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"4081_CR18","first-page":"1055","volume":"140","author":"CW Marlor","year":"1992","unstructured":"Marlor CW, Webb DL, Bombara MP, Greve JM, Blue ML (1992) Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor. Am J Pathol 140(5):1055\u20131060","journal-title":"Am J Pathol"},{"issue":"3","key":"4081_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","volume":"138","author":"E Scala","year":"2004","unstructured":"Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, De Pita O, Puddu P, Paganelli R, Russo G (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138(3):540\u2013546. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02642.x","journal-title":"Clin Exp Immunol"},{"key":"4081_CR20","unstructured":"Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker J.G., Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M (2016) The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clin and Exp Rheumatol 34 (Suppl 100):129\u2013136"},{"issue":"11","key":"4081_CR21","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hooden van den","year":"2013","unstructured":"van den Hooden F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131745","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4081_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/ard.2007.080424","volume":"67","author":"F Iannone","year":"2008","unstructured":"Iannone F, Riccardi MT, Guiducci S, Bizzoca R, Cinelli M, Matucci-Cerinic M, Lapadula G (2008) Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension. Ann Rheum Dis 67(8):1121\u20131126. \n                    https:\/\/doi.org\/10.1136\/ard.2007.080424","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4081_CR23","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/art.22634","volume":"56","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P, Stefanadis C, Mavrikakis M (2007) Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum 56(6):1985\u20131993. \n                    https:\/\/doi.org\/10.1002\/art.22634","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4081_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/00015550152572976","volume":"81","author":"M Mittag","year":"2001","unstructured":"Mittag M, Beckheinrich P, Haustein UF (2001) Systemic sclerosis-related Raynaud\u2019s phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. Acta Derm Venereol 81(4):294\u2013297. \n                    https:\/\/doi.org\/10.1080\/00015550152572976","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"4081_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1046\/j.1365-2362.2002.01095.x","volume":"32","author":"A Mazzone","year":"2002","unstructured":"Mazzone A, Faggioli P, Cusa C, Stefanin C, Rondena M, Morelli B (2002) Effects of iloprost on adhesion molecules and F1 + 2 in peripheral ischemia. Eur J Clin Investig 32(12):882\u2013888. \n                    https:\/\/doi.org\/10.1046\/j.1365-2362.2002.01095.x","journal-title":"Eur J Clin Investig"},{"issue":"20","key":"4081_CR26","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Galie","year":"2009","unstructured":"Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493\u20132537. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehp297","journal-title":"Eur Heart J"},{"issue":"4","key":"4081_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00246-008-9374-1","volume":"30","author":"K Sungprem","year":"2009","unstructured":"Sungprem K, Khongphatthanayothin A, Kiettisanpipop P, Chotivitayatarakorn P, Poovorawan Y, Lertsapcharoen P (2009) Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease. Pediatr Cardiol 30(4):472\u2013476. \n                    https:\/\/doi.org\/10.1007\/s00246-008-9374-1","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"4081_CR28","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s10439-009-9684-3","volume":"37","author":"M Li","year":"2009","unstructured":"Li M, Scott DE, Shandas R, Stenmark KR, Tan W (2009) High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng 37(6):1082\u20131092. \n                    https:\/\/doi.org\/10.1007\/s10439-009-9684-3","journal-title":"Ann Biomed Eng"},{"issue":"2","key":"4081_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/art.1780380206","volume":"38","author":"MS Gruschwitz","year":"1995","unstructured":"Gruschwitz MS, Hornstein OP, von Den Driesch P (1995) Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 38(2):184\u2013189. \n                    https:\/\/doi.org\/10.1002\/art.1780380206","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4081_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10067-004-0987-3","volume":"24","author":"A Kuryliszyn-Moskal","year":"2005","unstructured":"Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S (2005) Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 24(2):111\u2013116. \n                    https:\/\/doi.org\/10.1007\/s10067-004-0987-3","journal-title":"Clin Rheumatol"},{"issue":"7","key":"4081_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10067-009-1124-0","volume":"28","author":"HH Sawaya","year":"2009","unstructured":"Sawaya HH, de Souza RB, Carrasco S, Goldenstein-Schainberg C (2009) Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations. Clin Rheumatol 28(7):847\u2013851. \n                    https:\/\/doi.org\/10.1007\/s10067-009-1124-0","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4081_CR32","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","volume":"185","author":"A Yoshizaki","year":"2010","unstructured":"Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, Muroi E, Hara T, Ogawa F, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S (2010) Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 185(4):2502\u20132515. \n                    https:\/\/doi.org\/10.4049\/jimmunol.0901778","journal-title":"J Immunol"},{"key":"4081_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejr.2010.06.001","volume":"33","author":"AI Alzawawy","year":"2011","unstructured":"Alzawawy AI, Suliman I, Hamimi A, Elsawy N, Albordiny MM (2011) Serum soluble vascular cell adhesion molecule-1 (sVCAM-1) in scleroderma patients and its relation to pulmonary involvement and disease activity. The Egypt Rheumatol 33:21\u201326. \n                    https:\/\/doi.org\/10.1016\/j.ejr.2010.06.001","journal-title":"The Egypt Rheumatol"},{"issue":"6","key":"4081_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10753-004-6647-6","volume":"28","author":"PG Tsoutsou","year":"2004","unstructured":"Tsoutsou PG, Gourgoulianis KI, Petinaki E, Mpaka M, Efremidou S, Maniatis A, Molyvdas PA (2004) ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis. Inflamm 28(6):359\u2013364. \n                    https:\/\/doi.org\/10.1007\/s10753-004-6647-6","journal-title":"Inflamm"},{"issue":"1","key":"4081_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1164\/rccm.201101-0058OC","volume":"185","author":"TJ Richards","year":"2012","unstructured":"Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, Klesen M, Zhang Y, Gibson KF (2012) Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 185(1):67\u201376. \n                    https:\/\/doi.org\/10.1164\/rccm.201101-0058OC\n                    \n                   Erratum in: Am J Respir Crit Care Med. 185(4):464","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"4081_CR36","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.cellsig.2015.09.003","volume":"27","author":"M Agassandian","year":"2015","unstructured":"Agassandian M, Tedrow JR, Sembrat J, Kass DJ, Zhang Y, Goncharova EA, Kaminski N, Mallampalli RK, Vuga LJ (2015) VCAM-1 is a TGF-\u03b21 inducible gene upregulated in idiopathic pulmonary fibrosis. Cell Signal 27(12):2467\u20132473. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2015.09.003","journal-title":"Cell Signal"},{"issue":"6","key":"4081_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130166","volume":"10","author":"A Borghini","year":"2015","unstructured":"Borghini A, Manetti M, Nacci F, Bellando-Randone S, Guiducci S, Matucci-Cerinic M, Ibba-Manneschi L, Weber E (2015) Systemic sclerosis sera impair angiogenic performance of dermal microvascular endothelial cells: therapeutic implications of cyclophosphamide. PLoS One 10(6):e0130166. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0130166","journal-title":"PLoS One"},{"issue":"8","key":"4081_CR38","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/art.11081","volume":"48","author":"S Apras","year":"2003","unstructured":"Apras S, Ertenli I, Ozbalkan Z, Kiraz S, Ozturk MA, Haznedaroglu IC, Cobankara V, Pay S, Calguneri M (2003) Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis Rheum 48(8):2256\u20132261. \n                    https:\/\/doi.org\/10.1002\/art.11081","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4081-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T19:32:13Z","timestamp":1555961533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4081"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4081-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"21 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Vivek Thakkar has received honoraria for speaking from Actelion and has been on advisory boards for Actelion and GSK. The co-authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}